[go: up one dir, main page]

AU2001286064A1 - Treatment of drug resistant organisms - Google Patents

Treatment of drug resistant organisms

Info

Publication number
AU2001286064A1
AU2001286064A1 AU2001286064A AU8606401A AU2001286064A1 AU 2001286064 A1 AU2001286064 A1 AU 2001286064A1 AU 2001286064 A AU2001286064 A AU 2001286064A AU 8606401 A AU8606401 A AU 8606401A AU 2001286064 A1 AU2001286064 A1 AU 2001286064A1
Authority
AU
Australia
Prior art keywords
treatment
drug resistant
resistant organisms
organisms
aureurs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286064A
Inventor
Nigel Benjamin
Anthony Ormerod
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Aberdeen
Original Assignee
University of Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Aberdeen filed Critical University of Aberdeen
Publication of AU2001286064A1 publication Critical patent/AU2001286064A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The products of the acidification of nitrite are useful to control multiply drug resistant bacteria, such as methicillin resistant S. aureurs.
AU2001286064A 2000-09-08 2001-09-10 Treatment of drug resistant organisms Abandoned AU2001286064A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0022084.8A GB0022084D0 (en) 2000-09-08 2000-09-08 Treatment of multiply antibiotic-resistant organisms
GB0022084 2000-09-08
PCT/GB2001/004048 WO2002020026A2 (en) 2000-09-08 2001-09-10 Treatment of drug resistant organisms with nitric oxide

Publications (1)

Publication Number Publication Date
AU2001286064A1 true AU2001286064A1 (en) 2002-03-22

Family

ID=9899110

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286064A Abandoned AU2001286064A1 (en) 2000-09-08 2001-09-10 Treatment of drug resistant organisms

Country Status (9)

Country Link
US (1) US20040037897A1 (en)
EP (1) EP1315509B1 (en)
JP (1) JP5634655B2 (en)
AT (1) ATE369140T1 (en)
AU (1) AU2001286064A1 (en)
DE (1) DE60129823T2 (en)
ES (1) ES2291345T3 (en)
GB (1) GB0022084D0 (en)
WO (1) WO2002020026A2 (en)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
US7846141B2 (en) 2002-09-03 2010-12-07 Bluesky Medical Group Incorporated Reduced pressure treatment system
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
SE0300971D0 (en) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in the treatment of inflammation
ES2713058T3 (en) * 2003-04-23 2019-05-17 Univ Akron Reactive materials sequestered
AU2004255268B2 (en) 2003-07-09 2010-04-01 Loma Linda University Use of nitrite salts for the treatment of cardiovascular conditions
US7909805B2 (en) 2004-04-05 2011-03-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US10058642B2 (en) 2004-04-05 2018-08-28 Bluesky Medical Group Incorporated Reduced pressure treatment system
US8062272B2 (en) 2004-05-21 2011-11-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
GB0409446D0 (en) 2004-04-28 2004-06-02 Smith & Nephew Apparatus
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
CA2576957C (en) 2004-08-18 2013-04-02 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
US7618594B2 (en) 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
DK1871433T3 (en) 2005-03-24 2009-08-10 Nolabs Ab Cosmetic treatment with nitric oxide, device for performing this treatment and manufacturing process therefor
US8557300B2 (en) * 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
EP1888510A4 (en) 2005-05-27 2013-01-16 Univ North Carolina NITRIC OXIDE-LIBERATING PARTICLES FOR NITRIC OXIDE THERAPY AND BIOMEDICAL APPLICATIONS
US7288622B1 (en) * 2006-09-19 2007-10-30 Issar Pharmaceuticals Pvt Ltd Composition for treatment of burns and wounds
GB0618711D0 (en) * 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
KR20100021564A (en) * 2007-03-27 2010-02-25 노랩스 에이비 Topical dermal delivery device for nitric oxide delivery
US7718677B2 (en) * 2007-04-02 2010-05-18 Parkinson's Institute Methods and compositions for reduction of side effects of therapeutic treatments
US9278157B2 (en) 2007-08-09 2016-03-08 Insense Limited Nitric oxide-generating skin dressings
GB0715556D0 (en) * 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
US8399005B2 (en) 2007-10-12 2013-03-19 University Of North Carolina At Chapel Hill Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
US20090130233A1 (en) * 2007-10-24 2009-05-21 Baker Christopher G Two part lotion
ES2555204T3 (en) 2007-11-21 2015-12-29 T.J. Smith & Nephew Limited Suction and bandage device
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
CN101868203B (en) 2007-11-21 2014-10-22 史密夫及内修公开有限公司 Wound dressing
GB0723875D0 (en) 2007-12-06 2008-01-16 Smith & Nephew Wound management
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
US20130096518A1 (en) 2007-12-06 2013-04-18 Smith & Nephew Plc Wound filling apparatuses and methods
WO2009086470A2 (en) * 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
US7914743B2 (en) 2008-01-28 2011-03-29 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
GB0803564D0 (en) 2008-02-27 2008-04-02 Smith & Nephew Fluid collection
US8607785B2 (en) 2008-08-21 2013-12-17 Geno Llc Systems and devices for generating nitric oxide
EP2334279A4 (en) * 2008-10-16 2013-03-20 Novan Inc Nitric oxide releasing particles for oral care applications
US20120003293A1 (en) * 2008-10-30 2012-01-05 Chris Miller Nitric oxide-releasing dressings
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
GB0902816D0 (en) 2009-02-19 2009-04-08 Smith & Nephew Fluid communication path
CA2763804C (en) 2009-06-22 2018-02-06 Geno Llc Nitric oxide therapies
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
BR112012003792B1 (en) 2009-08-21 2020-05-19 Novan Inc topical composition, and, use of topical composition
EP2488591A1 (en) * 2009-10-13 2012-08-22 Novan, Inc. Nitric oxide-releasing coatings
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
CN107033596A (en) 2010-11-25 2017-08-11 史密夫及内修公开有限公司 Composition I-II and products thereof and purposes
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
ES2695173T3 (en) 2011-02-28 2019-01-02 Novan Inc Silica particles modified with S-nitrosothiol that release nitric oxide and methods of manufacturing them
JP6277124B2 (en) 2011-07-05 2018-02-07 ノヴァン，インコーポレイテッド Topical composition
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
EP2968647B1 (en) 2013-03-15 2022-06-29 Smith & Nephew plc Wound dressing sealant and use thereof
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
US10206947B2 (en) 2013-08-08 2019-02-19 Novan, Inc. Topical compositions and methods of using the same
KR102428738B1 (en) 2013-08-08 2022-08-02 노반, 인크. Topical compositions and methods of using the same
EP3698775A1 (en) 2014-07-11 2020-08-26 Novan Inc. Topical antiviral compositions and methods of using the same
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
WO2016010988A1 (en) 2014-07-14 2016-01-21 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
US10849864B2 (en) 2015-07-28 2020-12-01 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
EP3347096A4 (en) * 2015-09-09 2019-05-15 Advanced Inhalation Therapies (AIT) Ltd. INHALATION TREATMENT OF NITRIC OXIDE FOR INFANTS AFFECTING BRONCHIOLITE
DK3407900T3 (en) 2016-01-27 2024-04-02 Syk Tech Llc Apparatus for topical application of nitrous oxide and methods
WO2017147295A1 (en) * 2016-02-25 2017-08-31 The Regents Of The University Of Michigan Nitric oxide generating formulations and kits
JP7090549B2 (en) 2016-03-02 2022-06-24 ノヴァン，インコーポレイテッド Therapeutic compositions for inflammation and their treatment methods
CN109310630A (en) 2016-04-13 2019-02-05 诺万公司 Compositions, systems, kits and methods for treating infections
WO2019157295A1 (en) * 2018-02-09 2019-08-15 The Trustees Of Columbia University In The City Of New York Treating infections using inhibitor of cbb3-type oxidases
GB2579240B (en) * 2018-11-27 2020-12-16 Attgeno Ab New processes, compositions and medical uses
EP3980373A1 (en) * 2019-06-04 2022-04-13 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
EP3980032A1 (en) * 2019-06-04 2022-04-13 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
WO2021214440A1 (en) 2020-04-23 2021-10-28 Thirty Respiratory Limited Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2
CN115768413B (en) * 2020-04-23 2025-10-24 三十呼吸有限公司 Methods and compositions for treating and combating tuberculosis
GB202101543D0 (en) 2021-02-04 2021-03-24 Thirty Respiratory Ltd Vaping e-liquid composition and the use thereof
EP4452219A2 (en) 2021-12-22 2024-10-30 ConvaTec Limited Powder composition
EP4452231A1 (en) 2021-12-22 2024-10-30 ConvaTec Limited Powder composition
GB202302117D0 (en) 2023-02-14 2023-03-29 Thirty Respiratory Ltd Compositions, kits and combinations
WO2025005037A1 (en) * 2023-06-26 2025-01-02 積水化学工業株式会社 Resin composition and method for producing connection structure

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3164617B2 (en) * 1991-11-07 2001-05-08 株式会社日立製作所 Apparatus and method for deforming character / graphics
US5664086A (en) * 1993-04-16 1997-09-02 Adobe Systems Incorporated Method and apparatus for generating digital type font, and resulting fonts using generic font and descriptor file
PT746327E (en) * 1994-02-21 2004-06-30 Univ Aberdeen ACIDIFIED NITRITE AS AN ANTIMICROBIAL AGENT
US6426066B1 (en) * 2000-01-12 2002-07-30 California Pacific Labs, Inc. Use of physiologically balanced, ionized, acidic solution in wound healing
CA2402520A1 (en) * 2000-03-13 2001-09-20 Kenneth Beckman Biocidal methods and compositions

Also Published As

Publication number Publication date
JP5634655B2 (en) 2014-12-03
WO2002020026A3 (en) 2002-05-16
ES2291345T3 (en) 2008-03-01
DE60129823T2 (en) 2008-04-24
WO2002020026A2 (en) 2002-03-14
EP1315509B1 (en) 2007-08-08
JP2004508337A (en) 2004-03-18
US20040037897A1 (en) 2004-02-26
ATE369140T1 (en) 2007-08-15
EP1315509A2 (en) 2003-06-04
DE60129823D1 (en) 2007-09-20
GB0022084D0 (en) 2000-10-25

Similar Documents

Publication Publication Date Title
AU2001286064A1 (en) Treatment of drug resistant organisms
AU2002363819A1 (en) Microorganism for the biological detoxification of mycotoxins, namely ochratoxins and/or zearalenones, and corresponding method and use
AU2003202585A1 (en) Disubstituted thiazolyl carboxanilides and their use as microbicides
AU2003270163A1 (en) Methods for producing an anti-microbial plastic product
UA84025C2 (en) Normal;heading 1;heading 2;2-(QUINOXALIN-5-YLSULFONYLAMINO)-BENZAMIDE COMPOUNDS AS CCK2 MODULATORS
AU2003245928A1 (en) Antibacterial amide macrocycles
AU6901501A (en) Non-viable lactobacillus containing food product
AU2002354269A1 (en) Pharmaceutical and foodstuff products comprising deuterium for the treatment of diabetes and methods for production thereof
AU2003247279A1 (en) Furancarboxamides
AU2001260077A1 (en) Microfiltration using activated carbon
UA83203C2 (en) Thiazol-(bi)cycloalkyl-carboxanilides and their use for fighting against undesirable microorganisms
AU2003232775A1 (en) Oxathiincarboxamides
AU2003206926A1 (en) Cultivation method for micro-organisms and bioreactor
AU2004285314A1 (en) Aromatization of a milk product using at least one bacteria producing a bacteriocin and belonging to the Pediococcus genus
TW200510323A (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
WO2005012275A3 (en) Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators
MX2007004881A (en) Protecting bioactive food ingredients using microorganisms having reduced metabolizing capacity.
WO2001077365A3 (en) Antimicrobial methods and materials
FR2816632B1 (en) NOVEL BACTERIAL PHYTASES AND PROCESS FOR THE PRODUCTION THEREOF
AU2003227622A1 (en) Methylthiophene carboxanilides
DE60042753D1 (en) OF ANTIBIOTICS
PL1687014T3 (en) Use of additionally fermented distillers grains for preventing and/or treating increased blood sugar values
ZA200407358B (en) Microorganism for genetic therapeutic treatment ofproliferative diseases.
AU2002249173A1 (en) Phosphorylated glyoxalase i and its use
AU2358301A (en) Glyoxyl acid amides